The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 3 Regulatory News (DNA3)

Share Price Information for Doric Nimrod 3 (DNA3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.25
Bid: 51.50
Ask: 53.00
Change: 0.00 (0.00%)
Spread: 1.50 (2.913%)
Open: 53.00
High: 53.00
Low: 52.25
Prev. Close: 52.25
DNA3 Live PriceLast checked at -
Doric Nimrod Air Three is an Investment Trust

To obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of the fourth aircraft

27 Nov 2013 17:30

RNS Number : 1193U
DNA Alpha
27 November 2013
 



NOT FOR DISTRIBUTION OR RELEASE IN ANY JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

DORIC NIMROD AIR THREE LIMITED

DNA ALPHA LIMITED

Acquisition of the fourth aircraft

27 November 2013

 

Doric Nimrod Air Three Limited ("DNA3") and its wholly-owned subsidiary DNA Alpha Limited ("DNA Alpha") are pleased to announce that DNA Alpha, on 27 November 2013 purchased an Airbus A380-861 aircraft bearing manufacturer's serial number 133 (the "Aircraft") for the sum of US$245,000,000.

 

DNA Alpha also entered into an Aircraft Operating Lease Agreement with Emirates pursuant to which the Aircraft would be leased to Emirates.

 

This Aircraft is the fourth acquired by DNA Alpha and the final Airbus A380 aircraft to be acquired pursuant to the Initial Investment Process outlined in the DNA3 Prospectus dated 20 June 2013.

 

About the Company

DNA3 is a Guernsey domiciled company with shares admitted to the official list of the Channel Islands Stock Exchange and to trading on the Specialist Fund Market of the London Stock Exchange (LSE:DNA3).

DNA Alpha is a Guernsey domiciled company with pass through certificates admitted to listing on the Official List and trading on the Main Securities Market of the Irish Stock Exchange.

DNA3's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft (the "Assets").

To pursue its investment objective, DNA3 will seek to use the net proceeds of placings and other equity capital raisings, together with debt facilities (or instruments), to initially acquire Airbus A380 aircraft which will be leased to one or more major airlines.

The Company aims to provide Shareholders with an attractive total return comprising income, from distributions through the period of the Company's ownership of the Assets, and capital, upon the sale of the Assets.

 

For further information, please contact:

For administrative and company information:

Anson Fund Managers Limited

+44 (0) 1481 722260

 

 For shareholder information:

Nimrod Capital LLP

Richard Bolchover

Marc Gordon

+44 (0) 20 3355 6855

 

E&OE - In Transmission

 

END OF ANNOUNCEMENT

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFEUFWWFDSEFF
Date   Source Headline
28th Jul 20214:27 pmRNSHolding(s) in Company
15th Jul 20211:50 pmRNSQuarterly Report
15th Jul 20211:50 pmRNSDividend Declaration
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:36 pmRNSPrice Monitoring Extension
15th Apr 20213:30 pmRNSQuarterly Report
15th Apr 20213:30 pmRNSDividend Declaration
14th Jan 20215:00 pmRNSQuarterly Report
14th Jan 20215:00 pmRNSDividend Declaration
10th Dec 20205:36 pmRNSResult of AGM
10th Dec 20205:35 pmRNSHalf-year Report
22nd Oct 20203:30 pmRNSNotice of AGM
15th Oct 20204:00 pmRNSDividend Declaration
15th Oct 20204:00 pmRNSQuarterly Report
14th Sep 20203:55 pmRNSHolding(s) in Company
30th Jul 20204:34 pmRNSAnnual Financial Report
16th Jul 20203:01 pmRNSQuarterly Report
16th Jul 20203:00 pmRNSDividend Declaration
23rd Apr 202011:00 amRNSPrice Monitoring Extension
21st Apr 202011:30 amRNSQuarterly Report
17th Apr 20204:40 pmRNSSecond Price Monitoring Extn
17th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20202:30 pmRNSDividend Declaration
15th Apr 202012:44 pmRNSDirector/PDMR Shareholding
9th Apr 20205:06 pmRNSDirector/PDMR Shareholding
27th Mar 20202:35 pmRNSHolding(s) in Company
24th Mar 20204:34 pmRNSHolding(s) in Company
16th Mar 20204:44 pmRNSSecond Price Monitoring Extn
16th Mar 20204:39 pmRNSPrice Monitoring Extension
26th Feb 20205:27 pmRNSHolding(s) in Company
25th Feb 20203:04 pmRNSHolding(s) in Company
10th Feb 20204:45 pmRNSHolding(s) in Company
6th Feb 20202:00 pmRNSKepler Trust Intelligence: New Research
22nd Jan 20201:27 pmRNSHolding(s) in Company
16th Jan 20205:40 pmRNSQuarterly Report
16th Jan 20205:40 pmRNSDividend Declaration
16th Jan 20205:25 pmRNSDirectorate Change
13th Dec 20193:25 pmRNSHolding(s) in Company
25th Nov 20193:40 pmRNSHolding(s) in Company
22nd Nov 20194:45 pmRNSHalf-year Report
21st Nov 20194:35 pmRNSResult of AGM
18th Nov 201912:50 pmRNSProposed withdrawal of an AGM resolution
1st Nov 20193:19 pmRNSNotice of AGM
15th Oct 20199:05 amRNSSecond Price Monitoring Extn
15th Oct 20199:00 amRNSPrice Monitoring Extension
10th Oct 20192:00 pmRNSQuarterly Report
10th Oct 20192:00 pmRNSDividend Declaration
19th Aug 20194:17 pmRNSDirectorate Change
11th Jul 201912:30 pmRNSDividend Declaration
5th Jul 20194:15 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.